Clinical trial
An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.
NCT01842542 is registered in ClinicalTrials.gov with Neuronetics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.
- Lead sponsor
- Neuronetics
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2013
- Completion date
- August 31, 2015
- Enrollment
- 25 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.